Monitoring disease progression in spinocerebellar ataxias: implications for treatment and clinical research

References

• Sun YM, Lu C, Wu ZY. Spinocerebellar ataxia: relationship between phenotype and genotype - a review. Clin Genet. 2016;90:305–314.
   PubMed Web of Science ®Google Scholar
• Shakkottai VG, Fogel BL. Clinical neurogenetics: autosomal dominant spinocerebellar ataxia. Neurol Clin. 2013;31:987–1007.
   PubMed Web of Science ®Google Scholar
• Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9:885–894.
   PubMed Web of Science ®Google Scholar
• Klockgether T. Update on degenerative ataxias. Curr Opin Neurol. 2011;24:339–345.
   PubMed Web of Science ®Google Scholar
• Maas RP, van Gaalen J, Klockgether T, et al. The preclinical stage of spinocerebellar ataxias. Neurology. 2015;85:96–103.
   PubMed Web of Science ®Google Scholar
• Tezenas du Montcel S, Charles P, Goizet C, et al. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Arch Neurol. 2012;69:500–508.
   PubMedGoogle Scholar
• Saute JA, Donis KC, Serrano-Munuera C, et al. Ataxia rating scales–psychometric profiles, natural history and their application in clinical trials. Cerebellum. 2012;11:488–504.
   PubMed Web of Science ®Google Scholar
• Bürk K. Clinical scales of cerebellar ataxias. In:Manto M, Schmahmann JD, Rossi F,  Gruol DL, Koibuchi N, editors. Handbook of the cerebellum and cerebellar disorders. Dordrecht (Netherlands): Springer Science+Business Media B.V. 2013.p1785-1798.
   Google Scholar
• Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145:205–211.
   PubMed Web of Science ®Google Scholar
• Jacobi H, Bauer P, Giunti P, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology. 2011;77:1035–1041.
   PubMed Web of Science ®Google Scholar
• Ashizawa T, Figueroa KP, Perlman SL, et al. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis. 2013;8:177.
   PubMed Web of Science ®Google Scholar
• Jacobi H, du Montcel ST, Bauer P, et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol. 2015;14:1101–1108.
   PubMed Web of Science ®Google Scholar
• Lee YC, Liao YC, Wang PS, et al. Comparison of cerebellar ataxias: a three-year prospective longitudinal assessment. Mov Disord. 2011;26:2081–2087.
   PubMed Web of Science ®Google Scholar
• Yasui K, Yabe I, Yoshida K, et al. A 3-year cohort study of the natural history of spinocerebellar ataxia type 6 in Japan. Orphanet J Rare Dis. 2014;9:118.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Yoshida K, Matsushima A, et al. Natural history of spinocerebellar ataxia type 31: a 4-year prospective study. Cerebellum. 2017;16:518–524.
   PubMed Web of Science ®Google Scholar
• Jardim LB, Hauser L, Kieling C, et al. Progression rate of neurological deficits in a 10-year cohort of SCA3 patients. Cerebellum. 2010;9:419–428.
   PubMed Web of Science ®Google Scholar
• Schmitz-Hübsch T, Fimmers R, Rakowicz M, et al. Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology. 2010;74:678–684.
   PubMed Web of Science ®Google Scholar
• Chan E, Charles P, Ribai P, et al. Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias. Mov Disord. 2011;26:534–538.
   PubMed Web of Science ®Google Scholar
• Schmitz-Hübsch T, Tezenas du Montcel S, Baliko L, et al. Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients. Mov Disord. 2006;21:699–704.
   PubMed Web of Science ®Google Scholar
• França MC, D’Abreu A, Nucci A, et al. Progression of ataxia in patients with Machado-Joseph disease. Mov Disord. 2009;24:1387–1390.
   PubMed Web of Science ®Google Scholar
• Schmitz-Hübsch T, Du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–1720.
   PubMed Web of Science ®Google Scholar
• Jacobi H, Reetz K, du Montcel ST, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol. 2013;12:650–658.
   PubMed Web of Science ®Google Scholar
• Tezenas du Montcel S, Durr A, Bauer P, et al. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain. 2014;137:2444–2455.
   PubMed Web of Science ®Google Scholar
• Schmahmann JD, Gardner R, MacMore J, et al. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS. Mov Disord. 2009;24:1820–1828.
   PubMed Web of Science ®Google Scholar
• Sarah C, Francisco C, Ricardo M, et al. Brief ataxia rating scale: a reliable tool to rate ataxia in a short timeframe. Move Disord Clin Pract. 2016;3:621–623.
   Web of Science ®Google Scholar
• Velázquez-Pérez L, Cerecedo-Zapata CM, Hernández-Hernández O, et al. A comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7. Neurogenetics. 2015;16:11–21.
   PubMed Web of Science ®Google Scholar
• Kieling C, Rieder CR, Silva AC, et al. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3). Eur J Neurol. 2008;15:371–376.
   PubMed Web of Science ®Google Scholar
• Jacobi H, Rakowicz M, Rola R, et al. Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument. Cerebellum. 2013;12:418–428.
   PubMed Web of Science ®Google Scholar
• du Montcel ST, Charles P, Ribai P, et al. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain. 2008;131:1352–1361.
   PubMed Web of Science ®Google Scholar
• Schmitz-Hübsch T, Giunti P, Stephenson DA, et al. SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. Neurology. 2008;71:486–492.
   PubMed Web of Science ®Google Scholar
• Kubis N, Dürr A, Gugenheim M, et al. Polyneuropathy in autosomal dominant cerebellar ataxias: phenotype-genotype correlation. Muscle Nerve. 1999;22:712–717.
   PubMed Web of Science ®Google Scholar
• Linnemann C, Tezenas du Montcel S, Rakowicz M, et al. Peripheral neuropathy in spinocerebellar ataxia type 1, 2, 3, and 6. Cerebellum. 2016;15:165–173.
   PubMed Web of Science ®Google Scholar
• Abele M, Bürk K, Andres F, et al. Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain. 1997;120:2141–2148.
   PubMed Web of Science ®Google Scholar
• Schöls L, Amoiridis G, Büttner T, et al. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol. 1997;42:924–932.
   PubMed Web of Science ®Google Scholar
• Velázquez Pérez L, Sánchez Cruz G, Canales Ochoa N, et al. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. J Neurol Sci. 2007;263:158–164.
   PubMed Web of Science ®Google Scholar
• Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13:482–489.
   PubMed Web of Science ®Google Scholar
• Klockgether T, Schöls L, Abele M, et al. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD). J Neurol Neurosurg Psychiatry. 1999;66:222–224.
   PubMed Web of Science ®Google Scholar
• van de Warrenburg BP, Notermans NC, Schelhaas HJ, et al. Peripheral nerve involvement in spinocerebellar ataxias. Arch Neurol. 2004;61:257–261.
   PubMed Web of Science ®Google Scholar
• Manganelli F, Perretti A, Nolano M, et al. Electrophysiologic characterization in spinocerebellar ataxia 17. Neurology. 2006;66:932–934.
   PubMed Web of Science ®Google Scholar
• Ragno M, Perretti AC, Castaldo I, et al. Multimodal electrophysiologic follow-up study in 3 mutated but presymptomatic members of a spinocerebellar ataxia type 1 (SCA1) family. Neurol Sci. 2005;26:67–71.
   PubMed Web of Science ®Google Scholar
• Restivo DA, Giuffrida S, Rapisarda G, et al. Central motor conduction to lower limb after transcranial magnetic stimulation in spinocerebellar ataxia type 2 (SCA2). Clin Neurophysiol. 2000;111:630–635.
   PubMed Web of Science ®Google Scholar
• Velázquez-Pérez L, Rodríguez-Labrada R, Torres-Vega R, et al. Abnormal corticospinal tract function and motor cortex excitability in non-ataxic SCA2 mutation carriers: a TMS study. Clin Neurophysiol. 2016;127:2713–2719.
   PubMed Web of Science ®Google Scholar
• Horton LC, Frosch MP, Vangel MG, et al. Spinocerebellar ataxia type 7: clinical course, phenotype-genotype correlations, and neuropathology. Cerebellum. 2013;12:176–193.
   PubMed Web of Science ®Google Scholar
• Bürk K, Fetter M, Abele M, et al. Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol. 1999;246:789–797.
   PubMed Web of Science ®Google Scholar
• Moscovich M, Okun MS, Favilla C, et al. Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuroophthalmol. 2015;35:16–21.
   PubMed Web of Science ®Google Scholar
• Velázquez-Pérez L, Sánchez-Cruz G, Rodríguez-Labrada R, et al. Postural instability in prodromal spinocerebellar ataxia type 2: insights into cerebellar involvement before onset of permanent ataxia. Cerebellum. 2017;16:279–281.
   PubMed Web of Science ®Google Scholar
• Nanetti L, Alpini D, Mattei V, et al. Stance instability in preclinical SCA1 mutation carriers: a 4-year prospective posturography study. Gait Posture. 2017;57:11–14.
   PubMed Web of Science ®Google Scholar
• Kawai Y, Takeda A, Abe Y, et al. Cognitive impairments in Machado-Joseph disease. Arch Neurol. 2004;61:1757–1760.
   PubMedGoogle Scholar
• Bürk K, Bösch S, Globas C, et al. Executive dysfunction in spinocerebellar ataxia type 1. Eur Neurol. 2001;46:43–48.
   PubMed Web of Science ®Google Scholar
• Bürk K, Globas C, Bösch S, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol. 2003;250:207–211.
   PubMed Web of Science ®Google Scholar
• Klinke I, Minnerop M, Schmitz-Hübsch T, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum. 2010;9:433–442.
   PubMed Web of Science ®Google Scholar
• Le Pira F, Giuffrida S, Maci T, et al. Dissociation between motor and cognitive impairments in SCA2: evidence from a follow-up study. J Neurol. 2007;254:1455–1456.
   PubMed Web of Science ®Google Scholar
• Fancellu R, Paridi D, Tomasello C, et al. Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2. J Neurol. 2013;260:3134–3143.
   PubMed Web of Science ®Google Scholar
• Roeske S, Filla I, Heim S, et al. Progressive cognitive dysfunction in spinocerebellar ataxia type 3. Mov Disord. 2013;28:1435–1438.
   PubMed Web of Science ®Google Scholar
• Moriarty A, Cook A, Hunt H, et al. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7. Orphanet J Rare Dis. 2016;11:82.
   PubMed Web of Science ®Google Scholar
• Bürk K, Globas C, Bösch S, et al. Cognitive deficits in spinocerebellar ataxia 2. Brain. 1999;122:769–777.
   PubMed Web of Science ®Google Scholar
• Dürr A, Smadja D, Cancel G, et al. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain. 1995;118:1573–1581.
   PubMed Web of Science ®Google Scholar
• Trojano L, Chiacchio L, Grossi D, et al. Determinants of cognitive disorders in Autosomal Dominant Cerebellar Ataxia type 1. J Neurol Sci. 1998;157:162–167.
   PubMed Web of Science ®Google Scholar
• Globas C, Bösch S, Zühlke C, et al. The cerebellum and cognition. Intellectual function in spinocerebellar ataxia type 6 (SCA6). J Neurol. 2003;250:1482–1487.
   PubMed Web of Science ®Google Scholar
• Schmitz-Hübsch T, Coudert M, Giunti P, et al. Self-rated health status in spinocerebellar ataxia–results from a European multicenter study. Mov Disord. 2010;25:587–595.
   PubMed Web of Science ®Google Scholar
• Sánchez-López CR, Perestelo-Pérez L, Escobar A, et al. Health-related quality of life in patients with spinocerebellar ataxia. Neurologia. 2017;32:143–151.
   PubMed Web of Science ®Google Scholar
• Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, et al. Depression comorbidity in spinocerebellar ataxia. Mov Disord. 2011;26:870–876.
   PubMed Web of Science ®Google Scholar
• Mascalchi M, Vella A. Magnetic resonance and nuclear medicine imaging in ataxias. Handb Clin Neurol. 2012;103:85–110.
   PubMedGoogle Scholar
• Wang JL, Xiao B, Cui XX, et al. Analysis of SCA2 and SCA3/MJD repeats in Parkinson’s disease in mainland China: genetic, clinical, and positron emission tomography findings. Mov Disord. 2009;24:2007–2011.
   PubMed Web of Science ®Google Scholar
• Oh M, Kim JS, Oh JS, et al. Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography. PLoS One. 2017;12:e0173275.
   PubMed Web of Science ®Google Scholar
• Soong B, Liu R, Wu L, et al. Metabolic characterization of spinocerebellar ataxia type 6. Arch Neurol. 2001;58:300–304.
   PubMedGoogle Scholar
• Wüllner U, Reimold M, Abele M, et al. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch Neurol. 2005;62:1280–1285.
   PubMedGoogle Scholar
• Deistung A, Stefanescu MR, Ernst TM, et al. Structural and functional magnetic resonance imaging of the cerebellum: considerations for assessing cerebellar ataxias. Cerebellum. 2016;15:21–25.
   PubMed Web of Science ®Google Scholar
• Stefanescu MR, Dohnalek M, Maderwald S, et al. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich’s ataxia. Brain. 2015;138:1182–1197.
   PubMed Web of Science ®Google Scholar
• Nigri A, Visani E, Bertolino N, et al. Cerebellar involvement in patients with mild to moderate myoclonus due to EPM1: structural and functional mri findings in comparison with healthy controls and ataxic patients. Brain Topogr. 2017;30:380–389.
   PubMed Web of Science ®Google Scholar
• Reetz K, Dogan I, Rolfs A, et al. Investigating function and connectivity of morphometric findings-exemplified on cerebellar atrophy in spinocerebellar ataxia 17 (SCA17). Neuroimage. 2012;62:1354–1366.
   PubMed Web of Science ®Google Scholar
• Higgins JJ, Harvey-White JD, Nee LE, et al. Brain MRI, lumbar CSF monoamine concentrations, and clinical descriptors of patients with spinocerebellar ataxia mutations. J Neurol Neurosurg Psychiatry. 1996;61:591–595.
   PubMed Web of Science ®Google Scholar
• Reetz K, Lencer R, Hagenah JM, et al. Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17. Cerebellum. 2010;9:210–217.
   PubMed Web of Science ®Google Scholar
• D’Abreu A, França MC, Yasuda CL, et al. Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study. J Neuroimaging. 2012;22:285–291.
   PubMed Web of Science ®Google Scholar
• Reetz K, Costa AS, Mirzazade S, et al. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain. 2013;136:905–911.
   PubMed Web of Science ®Google Scholar
• Mascalchi M, Diciotti S, Giannelli M, et al. Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study. PLoS One. 2014;9:e89410.
   PubMed Web of Science ®Google Scholar
• Mascalchi M, Toschi N, Giannelli M, et al. Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study. AJNR Am J Neuroradiol. 2015;36:1096–1101.
   PubMed Web of Science ®Google Scholar
• Klockgether T, Skalej M, Wedekind D, et al. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain. 1998;121:1687–1693.
   PubMed Web of Science ®Google Scholar
• Della Nave R, Ginestroni A, Tessa C, et al. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. Neuroimage. 2008;43:10–19.
   PubMed Web of Science ®Google Scholar
• Schulz JB, Borkert J, Wolf S, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage. 2010;49:158–168.
   PubMed Web of Science ®Google Scholar
• Goel G, Pal PK, Ravishankar S, et al. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study. Parkinsonism Relat Disord. 2011;17:521–527.
   PubMed Web of Science ®Google Scholar
• Bürk K, Abele M, Fetter M, et al. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 1996;119:1497–1505.
   PubMed Web of Science ®Google Scholar
• Adanyeguh IM, Henry PG, Nguyen TM, et al. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov Disord. 2015;30:662–670.
   PubMed Web of Science ®Google Scholar
• Oz G, Iltis I, Hutter D, et al. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum. 2011;10:208–217.
   PubMed Web of Science ®Google Scholar
• Mercadillo RE, Galvez V, Díaz R, et al. Parahippocampal gray matter alterations in Spinocerebellar Ataxia Type 2 identified by voxel based morphometry. J Neurol Sci. 2014;347:50–58.
   PubMed Web of Science ®Google Scholar
• Della Nave R, Ginestroni A, Tessa C, et al. Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study. Mov Disord. 2008;23:899–903.
   PubMed Web of Science ®Google Scholar
• D’Agata F, Caroppo P, Boghi A, et al. Linking coordinative and executive dysfunctions to atrophy in spinocerebellar ataxia 2 patients. Brain Struct Funct. 2011;216:275–288.
   PubMed Web of Science ®Google Scholar
• Salvatore E, Tedeschi E, Mollica C, et al. Supratentorial and infratentorial damage in spinocerebellar ataxia 2: a diffusion-weighted MRI study. Mov Disord. 2014;29:780–786.
   PubMed Web of Science ®Google Scholar
• Lirng JF, Wang PS, Chen HC, et al. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS One. 2012;7:e47925.
   PubMed Web of Science ®Google Scholar
• Velázquez-Pérez L, Rodríguez-Labrada R, Cruz-Rivas EM, et al. Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease. Cerebellum. 2014;13:568–579.
   PubMed Web of Science ®Google Scholar
• Guimarães RP, D’Abreu A, Yasuda CL, et al. A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3. Mov Disord. 2013;28:1125–1132.
   PubMed Web of Science ®Google Scholar
• Eichler L, Bellenberg B, Hahn HK, et al. Quantitative assessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and 6: impact on clinical status. AJNR Am J Neuroradiol. 2011;32:890–897.
   PubMed Web of Science ®Google Scholar
• de Rezende TJ, D’Abreu A, Guimarães RP, et al. Cerebral cortex involvement in Machado-Joseph disease. Eur J Neurol. 2015;22:277–283.
   PubMed Web of Science ®Google Scholar
• Duarte JV, Faustino R, Lobo M, et al. Parametric fMRI of paced motor responses uncovers novel whole-brain imaging biomarkers in spinocerebellar ataxia type 3. Hum Brain Mapp. 2016;37:3656–3668.
   PubMed Web of Science ®Google Scholar
• Chen HC, Lirng JF, Soong BW, et al. The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type. Cerebellum Ataxias. 2014;1:17.
   PubMedGoogle Scholar
• Bang OY, Lee PH, Kim SY, et al. Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis. J Neurol Neurosurg Psychiatry. 2004;75:1452–1456.
   PubMed Web of Science ®Google Scholar
• Alcauter S, Barrios FA, Díaz R, et al. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study. Neuroimage. 2011;55:1–7.
   PubMed Web of Science ®Google Scholar
• Hernandez-Castillo CR, Alcauter S, Galvez V, et al. Disruption of visual and motor connectivity in spinocerebellar ataxia type 7. Mov Disord. 2013;28:1708–1716.
   PubMed Web of Science ®Google Scholar
• Hernandez-Castillo CR, Galvez V, Morgado-Valle C, et al. Whole-brain connectivity analysis and classification of spinocerebellar ataxia type 7 by functional MRI. Cerebellum Ataxias. 2014;1:2.
   PubMedGoogle Scholar
• Reetz K, Kleiman A, Klein C, et al. CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM study. PLoS One. 2011;6:e15125.
   PubMed Web of Science ®Google Scholar